Dr Cong (Ts'ong) Sui BSc, MBA, 2PhDs

Dr Cong (Ts'ong) Sui

School of Chemical Engineering
Research Fellow, Healthcare Technologies Institute

Contact details

Telephone
0121 371 8545
Email
c.sui@bham.ac.uk
Twitter
@Ts_ongSui
View my research portal
Address
Institute of Translational Medicine
Heritage Building (Old QE Hospital)
Mindelsohn Way
Birmingham
B15 2TH
UK

Dr Sui is a MedTech/HealthTech innovator and consultant with dual PhDs and an MBA-global health. He currently works at the West Midlands Health Tech Innovation Accelerator (WMHTIA).

Dr Sui provides both technical and business expertise to >30 companies and organisations. He devotes himself in the whole innovation journey, including the initial innovation, commercialising innovations, investing innovations and the final adoption into global health system. He aims to accelerate innovations and apply entrepreneurial skills to enhance the quality of healthcare services and address the global health challenges.

In addition to his role at WMHTIA, Dr Sui is a Research Fellow at the Healthcare Technologies Institute at the University of Birmingham. He has an academic research portfolio, with 12 published papers and 2 patents across diverse fields, including orthopaedics, biomaterial, nanotechnology, imaging and microencapsulation.

His industrial R&D work includes projects with leading FMCG companies, including Unilever, Firmenich, and Philips UK. Notably, he solved a critical problem in the FMCG sector through technological innovation, resulting in a patented solution that has garnered interest from more than 20 national and international companies.

Qualifications

  • Executive certificate, Newton Venture Program - Venture Capital Fundamentals, London Business School, UK, 2024.
  • Executive certificate, Leading Digital Transformation in Health Care, Harvard Medical School, Harvard University, US, 2024.
  • MBA in Global Health (Distinction), Global Business School for Health, University College London, UK, 2024.
  • PhD, Chemical Engineering, University of Birmingham, UK, 2018.
  • PhD, Biomaterials, Hefei National Laboratory for Physical Sciences at the Microscale, University of Science and Technology of China, Hefei, China, 2017.
  • BSc, 1st Class honours Equivalent, Biotechnology, Liaoning University, Shenyang, China, 2009.

Biography

Dr Sui was awarded an MBA in Global Health (with distinction) from the Global Business School for Health at University College London in 2024. He completed his first PhD in Biomaterials at Hefei National Laboratory for Physical Sciences at the Microscale, University of Science and Technology of China in 2017, followed by a second PhD in Chemical Engineering from the University of Birmingham in 2018. In addition to his academic achievements, Dr Sui also attended executive courses in Venture Capital Fundamentals at London Business School and Leading Digital Transformation in Health Care at Harvard University in 2024.

Dr Sui is currently working at the West Midlands Health Tech Innovation Accelerator (WMHTIA) and has been active in the entrepreneurial environment for over four years, providing both technical and business advice to >30 companies and organisations.

In 2024, Dr Sui was invited as an Investment Mentor to represent WMHTIA at the Asian Financial Forum (AFF). He joined a consulting project to assist the Saudi Arabia Ministry of Health in building an innovative national health system. He also acts as a contributor to establish the Global Health & Digital Innovation Foundation.

Additionally, Dr Sui is affiliated with the Healthcare Technologies Institute (HTI), an interdisciplinary network of over 70 academics working together to advance new technologies and treatments that promote better tissue healing and rehabilitation tools. His technological expertise contains calcium-based biomaterials and their bio-applications, pathological bone formation and its diagnosis, as well as microencapsulation and its applications. He has collaborated with global companies, including Unilever, Firmenich, and Philips.

Research

Research interests

  • Calcium-based biomaterials and their bio-applications
  • Pathological bone formation and its diagnosis
  • Microencapsulation and applications

 Current projects

Calcium-based biomaterials and their applications in hemostasis

Other activities

Investment mentor: Represent WMHTIA as an Investment Mentor at the Asian Financial Forum (AFF) 2024.

Publications

Dong, L.†, Xu, Y.J.†, Sui, C.†, Zhao, Y., Mao, L.B., Gebauer, D., Rosenberg, R., Avaro, J., et al. (2022). Highly hydrated paramagnetic amorphous calcium carbonate nanoclusters as a superior MRI contrast agent, Nature Communications, 13(1), pp.5088. † These authors contributed equally to this work.

Freer, S., Sui, C., Hanham, S. M., Grover, L and Navarro-Cia, M. (2021) A Hybrid Reflection Retrieval Method for Terahertz Dielectric Imaging of Human Bone. Biomedical Optics Express. (accepted).

Sui, C., Preece, J., Zhang, Z. and Yu, S. H. (2021) Efficient Encapsulation of Water Soluble Inorganic and Organic Actives in Melamine Formaldehyde Based Microcapsules for Control Release into an Aqueous Environment. Chemical Engineering Science, 229, 116103.

Sui, C., Preece, J., Yu, S. H. and Zhang, Z. (2018) Novel Encapsulation of Water Soluble Inorganic or Organic Ingredients in Melamine Formaldehyde Microcapsules to Achieve Their Sustained Release in an Aqueous Environment. RSC advances, 8, 29495-29498.

Sui, C., Preece, J. and Zhang, Z. (2017) Novel Polystyrene Sulfonate-Silica Microspheres as a Carrier of a Water Soluble Inorganic Salt (KCl) for Its Sustained Release, via a Dual-Release Mechanism. RSC advances, 7, 478-481.

Xu, Y., Dong, L., Lu, Y., Zhang, L., An, D., Gao, H., Yang, D., Hu, W., Sui, C., Xu, W. and Yu, S. (2016) Magnetic hydroxyapatite nanoworms for magnetic resonance diagnosis of acute hepatic injury. Nanoscale 8(3), 1684-1690.

Sui, C., Lu, Y., Gao, H. L., Dong, L., Zhao, Y., Ouali, L., Benczédi, D., Jerri, H. and Yu, S. H. (2013) Synthesis of mesoporous calcium phosphate microspheres by chemical transformation process: their stability and encapsulation of carboxymethyl chitosan. Crystal Growth Design 13(7): 3201-3207.

View all publications in research portal

Expertise

Health policy and practice.

Policy experience

Consulting project for the Saudi Arabia Ministry of Health: Emphasise the urgency of implementing blood biomarker diagnostics for Alzheimer's disease in primary healthcare centers across Saudi Arabia.